Neoadjuvant therapy with bevacizumab

被引：22

作者：

Gruenberger, T ^{[1
]}

Gruenberger, B

Scheithauer, W

机构：

[1] Med Univ Vienna, Dept Gen Surg, Vienna, Austria

[2] Med Univ Vienna, Dept Oncol, Vienna, Austria

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 16期

关键词：

D O I：

10.1200/JCO.2005.05.2910

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2592 / 2593

页数：2

共 13 条

[1] Improving long-term outcomes for patients with liver metastases from colorectal cancer [J].

Chong, G ;

Cunningham, D .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9063-9066

[2] Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab [J].

Ellis, LM ;

Curley, SA ;

Grothey, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4853-4855

[3] Worlds of gratitude: A contrastive study of acknowledgement texts in English and Italian research articles [J].

Giannoni, DS .

APPLIED LINGUISTICS, 2002, 23 (01) :1-31

[4]

Gruenberger T, 2005, J CLIN ONCOL, V23, p271S

[5]

Gruenberger T, 2004, J CLIN ONCOL, V22, p269S

[6]

GRUENBERGER T, 2004, ACTA MED AUSTRIACA, V36, P317

[7] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[8] Combined analysis of efficacy: The addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer [J].

Kabbinavar, FF ;

Hambleton, J ;

Mass, RD ;

Hurwitz, HL ;

Bergsland, E ;

Sarkar, S .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3706-3712

[9]

Nordlinger B, 2005, J CLIN ONCOL, V23, p253S

[10]

Scappaticci F, 2004, J CLIN ONCOL, V22, p252S

← 1 2 →